Beta Bionics, Inc. (NASDAQ:BBNX) Insider Mike Mensinger Acquires 33,350 Shares

Beta Bionics, Inc. (NASDAQ:BBNXGet Free Report) insider Mike Mensinger purchased 33,350 shares of the business’s stock in a transaction that occurred on Friday, January 31st. The shares were purchased at an average price of $17.00 per share, for a total transaction of $566,950.00. Following the completion of the acquisition, the insider now directly owns 59,019 shares in the company, valued at $1,003,323. The trade was a 129.92 % increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

Beta Bionics Stock Performance

Shares of NASDAQ:BBNX opened at $22.75 on Tuesday. Beta Bionics, Inc. has a 12 month low of $22.00 and a 12 month high of $24.50.

Beta Bionics Company Profile

(Get Free Report)

We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease.

Further Reading

Receive News & Ratings for Beta Bionics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beta Bionics and related companies with MarketBeat.com's FREE daily email newsletter.